<DOC>
	<DOCNO>NCT02028182</DOCNO>
	<brief_summary>The purpose study compare ascend dos investigational T.R.U.E . Test allergens market petrolatum reference allergen .</brief_summary>
	<brief_title>Clinical Evaluation Lyral® Dose Response Study</brief_title>
	<detailed_description>This single-center , double-blind , randomize study compare diagnostic performance ( primary ) safety ( secondary ) ascend dos hydroxyisohexyl 3-cyclohexene carboxaldehyde ( Lyral® ) 0.40 - 0.20 - 0.10 mg/cm²and control patch ( ß-cyclodextrin Povidone ( PVP ) ) , 20 adult subject clinical history contact dermatitis test positive ( current previous patch test ) Lyral® Fragrance Mix 2 .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Contact</mesh_term>
	<criteria>1 . Males females 18 year age old . 2 . Clinical history contact dermatitis positive patch test ( current previous ) either Lyral® Fragrance Mix 2 ; otherwise good general health . 3 . Unable become pregnant willing use acceptable method contraception prevent pregnancy female childbearing potential ; Inability become pregnant would include male subject female subject postmenopausal least 1 year , surgically sterile hysterectomy , bilateral ovariectomy , uterine ablation bilateral tubal ligation . Acceptable method contraception include : 1 ) systemic birth control ( type birth control least 3 month prior enter study continuation type birth control throughout study ) ; 2 ) double barrier method ( condom spermicide diaphragm spermicide ) ; 3 ) intra uterine device ; 4 ) vasectomize partner ; 5 ) abstinence sexual intercourse . 4 . Have read sign consent form able fulfill study requirement make required visit . 1 . Lactation pregnancy , determine urine pregnancy test ( UPT ) females childbearing potential . UPT must conduct prior patch placement . 2 . Treatment topical corticosteroid near test area previous 7 day . 3 . Treatment systemic corticosteroid immunosuppressives previous 7 day . ( Inhaled treatment permit . ) 4 . Treatment ultraviolet ( UV ) light , include tanning , previous 3 week . 5 . Acute dermatitis outbreak dermatitis near test area back . 6 . Participation another clinical study involve investigational drug , treatment device currently within previous 3 week . 7 . Unable comply activity restriction ( e.g. , protect test panel excess moisture due shower vigorous activity ) . 8 . Unable unwilling comply multiple return visit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Patch Test</keyword>
	<keyword>Allergy Testing</keyword>
	<keyword>Contact dermatitis</keyword>
	<keyword>Lyral allergen</keyword>
	<keyword>Fragrance Mix allergen</keyword>
</DOC>